← back to search

Alyssa N. Coyne

Johns Hopkins Medicine · US
Area of research
Neurology · Genetics
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, RNA Research and Splicing, and Genetic Neurodegenerative Diseases.
h-index
23
citations
2,870
works
57
NIH funding
primary concept
email

Recent publications

Sporadic ALS induced pluripotent stem cell derived neurons reveal hallmarks of TDP-43 loss of function
Nature Communications 2025cited by 11position: lastdoi
PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neurons
Nature Neuroscience 2024cited by 36position: middledoi
Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls
Nature Communications 2024cited by 12position: middledoi
G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons
Acta Neuropathologica 2023cited by 37position: lastdoi
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines
Nature Neuroscience 2022cited by 153position: middledoi
Nuclear pore complexes — a doorway to neural injury in neurodegeneration
Nature Reviews Neurology 2022cited by 94position: firstdoi
Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data
Nature Computational Science 2022cited by 50position: middledoi
Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS
Science Translational Medicine 2021cited by 141position: firstdoi
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
iScience 2021cited by 49position: middledoi
The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei
Acta Neuropathologica Communications 2021cited by 21position: firstdoi
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Acta Neuropathologica Communications 2021cited by 13position: firstdoi
G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD
Neuron 2020cited by 162position: firstdoi
CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation
Neuron 2019cited by 142position: middledoi
Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease
Neuron 2018cited by 453position: middledoi
Stress Granule Assembly Disrupts Nucleocytoplasmic Transport
Cell 2018cited by 425position: middledoi
Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimerrs Disease
SSRN Electronic Journal 2018cited by 0position: middledoi
Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS
Cell Reports 2017cited by 107position: firstdoi
Endocytosis regulates TDP-43 toxicity and turnover
Nature Communications 2017cited by 102position: middledoi
Failure to Deliver and Translate—New Insights into RNA Dysregulation in ALS
Frontiers in Cellular Neuroscience 2017cited by 57position: firstdoi
Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation
Human Molecular Genetics 2015cited by 96position: firstdoi
Futsch/MAP1B mRNA Is a Translational Target of TDP-43 and Is Neuroprotective in a<i>Drosophila</i>Model of Amyotrophic Lateral Sclerosis
Journal of Neuroscience 2014cited by 157position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey D. Rothstein · German Center for Neurodegenerative Diseases9 papers (2018–2025)Daniela C. Zarnescu · University of Arizona5 papers (2014–2017)Benjamin L. Zaepfel · University of Arizona5 papers (2015–2021)Frank Rigo · Ionis Pharmaceuticals (United States)4 papers (2018–2023)Jeffrey Johannesmeyer · University of Arizona3 papers (2014–2017)Lindsey R. Hayes · Allen Institute for Brain Science2 papers (2019–2020)J. Paul Taylor · University of Toronto2 papers (2015–2018)Patricia S. Estes · University of Arizona2 papers (2014–2015)Aaron D. Gitler · Stanford University2 papers (2015–2018)Kelly Bowen · Q Therapeutics (United States)2 papers (2018–2020)Frank Bennett · Johns Hopkins Medicine2 papers (2021–2023)Bhavani B. Siddegowda · University of Arizona2 papers (2014–2015)Victoria Baskerville · Johns Hopkins Medicine2 papers (2021–2023)Kathleen M. Cunningham · Integrated BioTherapeutics (United States)1 papers (2018–2018)Don W. Cleveland · University of California San Diego1 papers (2019–2019)Sampath Rapuri · Johns Hopkins Medicine1 papers (2023–2023)Thomas E. Lloyd · Johns Hopkins University1 papers (2018–2018)Ileana Lorenzini · Banner Sun Health Research Institute1 papers (2017–2017) · 1 papers (2015–2015)Ke Zhang · Nanjing University of Chinese Medicine1 papers (2018–2018)